FINWIRES · TerminalLIVE
FINWIRES

Cerebras has Several Potential Catalysts for Further Upside, Wedbush Says

By

Cerebras Systems (CBRS) reported relative upside to initial expectations, and although there were no surprises, several potential future catalysts could drive further upside, Wedbush Securities said in a note Wednesday.

The company reported modest upside to revenue and margins, driven by hardware sales exceeding the investment firm's expectations and higher cloud service pricing due to strong demand, according to the note.

The upside seems to carry into Q2 guidance, with revenue outperforming Wedbush's estimate by a similar magnitude. While gross margins are expected to contract as OpenAI revenue ramps up, the decline is less pronounced than the brokerage had previously modeled, creating upside through 2026, the note added.

Wedbush believes new products with improved performance, higher prices and margins, additional data center capacity, and strong demand for AI products could provide potential upside to its model, according to the note.

Wedbush kept an outperform rating on Cerebras and raised the price target to $280 from $270.

Shares of Cerebras were down 16% in Wednesday trading.

Price: $189.63, Change: $-37.09, Percent Change: -16.36%

Related Articles

Wire

Cerebras Systems Q1 Net Loss Narrows, Revenue Rises; Shares Fall After Hours

Cerebras Systems (CBRS) reported a Q1 net loss late Tuesday of $0.22 per diluted share, narrowing from the loss of $0.46 a year earlier.Analysts polled by FactSet expected a loss of $0.16.Revenue in the three months ended March 31 rose to $193.4 million from $99.5 million a year earlier.Analysts expected $181.2 million.The company expects Q2 non-GAAP revenue of about $194 million. Analysts project $177.7 million.Cerebras expects full-year non-GAAP revenue of $855 million to $865 million. Analysts forecast $828 million.Cerebras shares fell 7.6% in after-hours trading.

$CBRS
Wire

Top Cryptocurrencies Fall; Bitcoin Drops Below $63,000 Level

Top cryptocurrencies fell Tuesday, with Bitcoin (BTC-USD) dropping below the $63,000 level.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, fell almost 3.5% in the past 24 hours. The Nasdaq 100 fell 3.2%, the S&P 500 decreased 1.3%, and the Dow Jones Industrial Average was down 0.1%.Bitcoin dropped 3.2% to $62,259, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume rose 9.5% to $29.78 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, declined 4.3% to $1,657.XRP (XRP-USD) dropped 2.7%, BNB (BNB-USD) fell 2.7%, and Solana (SOL-USD) lost 5.3%. Dogecoin (DOGE-USD) declined 5.1%, and Cardano (ADA-USD) shed 5.5%.The US 10-year Treasury yield stood at 4.509% at 3 p.m. ET Tuesday, up from 4.493% Monday, while the five-year yield rose to 4.288% from 4.261%.The total market value of the cryptocurrency industry fell 2.9% in the past 24 hours to $2.14 trillion, with trading volume rising 0.5% to $72.42 billion.Price: $62270.80, Change: $-1680.71, Percent Change: -2.63%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD
Wire

Cosmos Health to Deploy AI-Powered Call Center at Pharma Distribution Unit

Cosmos Health (COSM) said Tuesday its pharmaceutical distribution subsidiary CosmoFarm will deploy an artificial intelligence-powered call center to support customer communications, order intake and routine support functions.The platform will include multilingual voice assistance, intelligent call routing, outbound campaign automation, back-end system integration and real-time reporting capabilities, the company said.

$COSM